This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Successfully Balancing The Needs of The Planet With The Needs of The Patient
Publications, Pharmaceutical, Product Solutions, Sustainability, Innovation & Insights, Device Innovations
Using digital healthcare to improve patient compliance and adherence
Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
Introducing PureHale® for targeted upper respiratory tract care
Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights
Aptar Pharma talks targeted drug delivery to the upper airways
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation
